The relationship between acute rejection and chronic rejection is highly dependent on specific MHC matching: A multi-strain rat heterotopic heart transplant study

Transplantation

Volumn 69, Issue 10, 2000, Pages 2173-2178

  Hosenpud, Jeffrey D ^a   Boyle, Timothy M ^a   Hensler, Heather ^a   Sanford, Gordon ^a   Khanna, Ashwani K ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CYTOMEGALOVIRUS INFECTION; DISEASE ACTIVITY; DISEASE ASSOCIATION; GRAFT REJECTION; HLA MATCHING; IMMUNOSUPPRESSIVE TREATMENT; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0034720550     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200005270-00037     Document Type: Article

References (23)

1. Almond PS, Matas A, Gillingham K, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993; 55: 752.
2. Basadpmma GP, Matas AJ, Gillingham KJ, et al. Early versus late acute renal allograft rejection: impact on chronic rejection. Transplantation 1993; 55: 993.
3. van Saase JLCM, van der Woude FJ, Thorogood J, et al. The relation between acute vascular and interstitial renal allograft rejection and subsequent chronic rejection. Transplantation 1995; 59: 1280.
4. Hosenpud JD, Shipley GD, Wagner CR. Cardiac allograft vasculopathy: current concepts, recent developments and future directions. J Heart Lung Transplant 1992; 11: 9.
5. Gao SZ, Schroeder JS, Alderman EL, et al. Prevalence of accelerated coronary artery disease in heart transplant survivors. Circulation 1989; 80: III-100.
6. Uretsky BF, Murali S, Reddy PS, et al. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation 1987; 76: 827.
7. Mehra MR, Ventura HO, Chambers RB, Ramireddy K, Smart FW, Stapleton DD. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal. J Heart Lung Transplant 1997; 16: 743.
8. Zhao XM, Citrin BS, Miller GG, et al. Association of acidic fibroblast growth factor and untreated low grade rejection with cardiac allograft vasculopathy. Transplantation 1995; 59: 1005.
9. Nakagawa T, Sukhova GK, Rabkin E, WInters GL, Schoen FJ, Libby P. Acute rejection accelerates graft coronary disease in transplanted rabbit hearts. Circulation 1995; 92: 987.
10. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer, PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989; 261 (24): 3561.
11. Loebe M, Schuler S, Zais O, Warnecke H, Fleck E, Hetzer R. Role of Cytomegalovirus infection in the development of coronary artery disease in the transplanted heart. J Heart Transplant 1990; 9 (6): 707.
12. McDonald K, Rector TS, Braunlin EA, Kubo SH, Olivari MT. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am J Cardiol 1989; 64 (5): 359.
13. Everett JP, Hershberger RE, Norman DJ, et al. Prolonged cytomegalovirus infection with viremia is associated with development of cardiac allograft vasculopathy. J Heart Lung Transplant 1992; 11 (3 Pt 2): S133.
14. Lemstrom KB, Bruning JH, Bruggeman CA, Lautenschlager IT, Hayry PJ. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimai thickening of rat aortic allografts. J Clin Invest 1993; 92: 549.
15. Lemstrom KB, Raisanen-Sokolowski AK, Hayry PJ, Koskinen PK. Triple drug immunosuppression significantly reduces aortic allograft arteriosclerosis in the rat. Arterioscler Thromb Vasc Biol 1996; 16: 553.
16. Lemstrom KB, Bruning JH, Bruggeman CA, et al. Cytomegalovirus infection-enhanced allograft arteriosclerosis is prevented by DHPG prophylaxis in the rat. Circulation 1994; 90: 1969.
17. Billingham ME, Gary NRB, Hammond EH, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: heart rejection study group. J Heart Transplant 1990; 9: 587.
18. Lemstrom K, Sihvola R, Bruggeman C, Hayry P, Koskinen P. Cytomegalovirus infection: enhanced cardiac allograft vasculopathy is abolished by DHPG prophylaxis in the rat. Circulation 1997; 95: 2614.
19. Reichenspurner H, Soni V, Nitschke M, et al. Enhancement of obliterative airway disease in rat tracheal allografts infected with recombinant rat cytomegalovirus. J Heart Lung Transplant 1998; 17: 439.
20. Beisser PS, Kaptein SJF, Beuken E, Bruggeman CA, Vink C. The Maastricht strain and the England strain of rat cytomegalovirus represent different betaherpesvirus species rather than strains. Virology 1998; 246: 341.
21. Hullett DA, Geraghty JG, Stoltenberg RL, Sollinger HW. The impact of acute rejection on the development of intimal hyperplasia associated with chronic rejection. Transplantation 1996; 62: 1842.
22. Shirwan H, Cajulis E, Makowka L, Cramer DV. Differential usage of the T cell receptor repertoire for allorecognition of heart, liver and kidney grafts. Transplantation 1995; 59: 1709.
23. Russell PS, Chase CM, Winn HJ, Colvin RB. Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity. J Immunol 1994; 152: 5135.